Outlook Therapeutics, Inc. SEC Filings http://ir.oncobiologics.com/ Outlook Therapeutics, Inc. SEC Filings en 424B3: Form of prospectus reflecting facts events constituting substantive change from last form http://ir.oncobiologics.com/sec-filings/sec-filing/424b3/0001144204-19-031046 Oncobiologics, Inc. Fri, 14 Jun 2019 17:26:38 -0400 Outlook Therapeutics, Inc. SEC Filings 8171 8-K: Report of unscheduled material events or corporate event http://ir.oncobiologics.com/sec-filings/sec-filing/8-k/0001144204-19-031045 Oncobiologics, Inc. Fri, 14 Jun 2019 17:24:38 -0400 Outlook Therapeutics, Inc. SEC Filings 8166 8-K: Report of unscheduled material events or corporate event http://ir.oncobiologics.com/sec-filings/sec-filing/8-k/0001144204-19-030477 Oncobiologics, Inc. Mon, 10 Jun 2019 17:19:12 -0400 Outlook Therapeutics, Inc. SEC Filings 8161 S-3: Simplified registration form http://ir.oncobiologics.com/sec-filings/sec-filing/s-3/0001144204-19-029513 Oncobiologics, Inc. Mon, 03 Jun 2019 17:20:42 -0400 Outlook Therapeutics, Inc. SEC Filings 8156 SC 13G: A statement of beneficial ownership of common stock by certain persons http://ir.oncobiologics.com/sec-filings/sec-filing/sc-13g/0001535610-19-000086 Oncobiologics, Inc. Wed, 22 May 2019 14:08:54 -0400 Outlook Therapeutics, Inc. SEC Filings 8141 8-K: Report of unscheduled material events or corporate event http://ir.oncobiologics.com/sec-filings/sec-filing/8-k/0001144204-19-026624 Oncobiologics, Inc. Wed, 15 May 2019 17:11:11 -0400 Outlook Therapeutics, Inc. SEC Filings 8136 10-Q: Quarterly report which provides a continuing view of a company's financial position http://ir.oncobiologics.com/sec-filings/sec-filing/10-q/0001144204-19-026623 Oncobiologics, Inc. Wed, 15 May 2019 17:09:20 -0400 Outlook Therapeutics, Inc. SEC Filings 8131 8-K: Report of unscheduled material events or corporate event http://ir.oncobiologics.com/sec-filings/sec-filing/8-k/0001144204-19-021631 Oncobiologics, Inc. Fri, 26 Apr 2019 17:12:56 -0400 Outlook Therapeutics, Inc. SEC Filings 8121 SC 13D/A: An amendment to a SC 13D filing http://ir.oncobiologics.com/sec-filings/sec-filing/sc-13da/0001144204-19-019932 Oncobiologics, Inc. Wed, 17 Apr 2019 06:08:36 -0400 Outlook Therapeutics, Inc. SEC Filings 8111 4: Statement of changes in beneficial ownership of securities http://ir.oncobiologics.com/sec-filings/sec-filing/4/0001209191-19-024794 Oncobiologics, Inc. Tue, 16 Apr 2019 17:38:10 -0400 Outlook Therapeutics, Inc. SEC Filings 8106